Eric K. Singhi: How Do We Choose as New Options Emerge for Patients With EGFR Exon 20 NSCLC?
Eric Singhi/faculty.mdanderson.org

Eric K. Singhi: How Do We Choose as New Options Emerge for Patients With EGFR Exon 20 NSCLC?

Eric K. Singhi, Assistant Professor at MD Anderson Cancer Center, shared on X:

“Save This Tweet if you see patients with EGFR exon 20 NSCLC

Beautiful discussion by Luda Bazhenova here at WCLC26.

As new options emerge for our patients, how do we choose?”

Eric K. Singhi: How Do We Choose as New Options Emerge for Patients With EGFR Exon 20 NSCLC?

Other posts featuring Eric K. Singhi on OncoDaily.